Essential news from ASCO 2023 in primary resectable and advanced or metastatic pancreatic cancer

被引：0
|
作者：
Reimann, Patrick [1 ,2 ]
Winder, Thomas [1 ,3 ]
机构：
[1] Feldkirch Acad Teaching Hosp, Dept Internal Med 2, Carinagasse 47, A-6800 Feldkirch, Austria
[2] Private Univ Principal Liechtenstein, Triesen, Liechtenstein
[3] Univ Zurich, Zurich, Switzerland
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2023年 / 16卷 / 04期
关键词：
Pancreatic cancer treatment; Primary resectable cancer; Metastatic; Neoadjuvant therapy; First-line treatment; PHASE-II; FOLFIRINOX;
D O I：
10.1007/s12254-023-00931-z
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this short review, we aim to summarize the essential news and highlights in pancreatic cancer that were presented at ASCO 2023. We focus in particular on primary resectable as well as advanced or metastatic disease. Therefore, the first results of the NORPACT-1 trial and the updated data from the NAPOLI-3 study are summarized. We discuss these studies and their potential influence on daily clinical practice with regard to current standard of care.
引用
收藏
页码：225 / 229
页数：5
相关论文
共 50 条
  • [1] Essential news from ASCO 2023 in primary resectable and advanced or metastatic pancreatic cancer
    Patrick Reimann
    Thomas Winder
    memo - Magazine of European Medical Oncology, 2023, 16 : 225 - 229
  • [2] Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer
    Del Chiaro, Marco
    Valente, Roberto
    Arnelo, Urban
    JAMA SURGERY, 2017, 152 (11) : 1057 - 1057
  • [3] Metastatic Pancreatic Cancer: ASCO Guideline Update
    Sohal, Davendra P. S.
    Kennedy, Erin B.
    Cinar, Pelin
    Conroy, Thierry
    Copur, Mehmet S.
    Crane, Christopher H.
    Garrido-Laguna, Ignacio
    Lau, Michelle W.
    Johnson, Tyler
    Krishnamurthi, Smitha
    Moravek, Cassadie
    O'Reilly, Eileen M.
    Philip, Philip A.
    Pant, Shubham
    Shah, Manish A.
    Sahai, Vaibhav
    Uronis, Hope E.
    Zaidi, Neeha
    Laheru, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (27) : 3217 - +
  • [4] Chemotherapy for resectable and advanced pancreatic cancer
    Berlin, JD
    Rothenberg, M
    ONCOLOGY-NEW YORK, 2001, 15 (10): : 1241 - +
  • [5] Endometrial cancer: news from ASCO
    Edgar Petru
    memo - Magazine of European Medical Oncology, 2022, 15 : 275 - 277
  • [6] Endometrial cancer: news from ASCO
    Petru, Edgar
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (04) : 275 - 277
  • [7] Neoadjuvant Therapy is Essential for Resectable Pancreatic Cancer
    Xu, Jin-Zhi
    Wang, Wen-Quan
    Zhang, Shi-Rong
    Xu, Hua-Xiang
    Wu, Chun-Tao
    Qi, Zi-Hao
    Gao, He-Li
    Li, Shuo
    Ni, Quan-Xing
    Yu, Xian-Jun
    Liu, Liang
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (40) : 7196 - 7211
  • [8] News from AACR and ASCO 2023 for dermato-oncology
    Gutzmer, Ralf
    Hassel, Jessica C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 (09): : 1085 - 1086
  • [9] Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update
    Sohal, Davendra P. S.
    Kennedy, Erin B.
    Khorana, Alok
    Copur, Mehmet S.
    Crane, Christopher H.
    Garrido-Laguna, Ignacio
    Krishnamurthi, Smitha
    Moravek, Cassadie
    O'Reilly, Eileen M.
    Philip, Philip A.
    Ramanathan, Ramesh K.
    Ruggiero, Joseph T.
    Shah, Manish A.
    Urba, Susan
    Uronis, Hope E.
    Lau, Michelle W.
    Laheru, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (24) : 2545 - +
  • [10] Breast Cancer News from ASCO 2013
    Dall, Peter
    Liedtke, Cornelia
    Rack, Brigitte
    Schuetz, Florian
    Stickeler, Elmar
    BREAST CARE, 2013, 8 (04) : 307 - 309
12345